期刊文献+

羟基喜树碱双途径联合化疗治疗中晚期胃肠癌 被引量:3

Treatment of median and Advanced Gastrointestinal Cancer by Hydroxy Camptothecin intravenous and intraperitoneal Injection
下载PDF
导出
摘要 目的 提高中晚期胃肠癌化疗疗效。方法 静脉、腹腔双途径应用羟基喜树碱为主的联合化疗。结果 治疗组有效率60% ,对照组有效率45.5% ,明显高于对照组,但无统计学差异,P>0.05。生存质量明显提高,人均karnofsky评分较对照组提高6.5分。P< 0.05,有显著性差异。结论 联合羟基喜树碱组成ELFO及LFO方案双途径联合化疗对中晚期胃肠癌近期疗效满意。 ? Objective To improve the effect of chemotherapy of middle advanced gastrointestinal cancer.Methods Hydroxy camptothecin was combined mainly with other medicine (ELFO or LFO)by intravenous and intraperitoneal injection.Results Effective rate is 60% in treated group,but it is 45% in control group,thedifference was significant,P>0.05,Life quality of treated group was improved,the score of Karnofsky increased 6.5, the differece was significant P<0.05.Conclusion The combined chemotherapy of hydroxy camptothecin (ELFO or LFO) of intravenous and intraperitoneal route is satisfactory in short term for middle and advanced gastrointestinal cancer. 〔
作者 周成英
出处 《中国肿瘤临床与康复》 1999年第4期91-92,共2页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 中晚期胃肠癌 羟基喜树碱 双途径 Median and advanced gastrointestinal cancer Hydroxy camptothecin Dual route.
  • 相关文献

参考文献5

共引文献104

同被引文献5

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部